Loading clinical trials...
Loading clinical trials...
Memantine for Prevention of Cognitive Decline During Adjuvant or Neoadjuvant Chemotherapy in Patients With Breast Cancer
Conditions
Interventions
Memantine
Locations
1
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
September 25, 2019
Primary Completion Date
April 4, 2022
Completion Date
April 4, 2022
Last Updated
April 20, 2023
NCT07457138
NCT02290834
NCT06397469
NCT07332299
NCT07315724
NCT04583800
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions